PORTLAND, Ore. – Scientists at Oregon State University have developed an innovative nanomaterial that targets cancer cells while sparing healthy tissue.
According to the researchers, this breakthrough could revolutionize cancer treatment by using oxidative stress to kill cancer cells. The study, led by Oleh and Olena Taratula and Chao Wang, was published in Advanced Functional Materials. The research highlights a new metal-organic framework, or MOF, that can generate two types of reactive oxygen species, enhancing the effectiveness of chemodynamic therapy (CDT).
“Existing CDT agents are limited,” said researcher Oleh Taratula. The new nanoagent offers superior catalytic efficiency and has shown potent toxicity in cancer cells with minimal harm to healthy cells…